Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Financings

Comprehensive Healthcare extends private placement

CHS · Price

Executive Summary

  • Comprehensive Healthcare Systems Inc. has announced an extension of the second tranche of its non-brokered private placement, extending the subscription period by 30 days until April 13, 2026.
  • The extension specifically targets the second tranche of units priced at 52 cents per unit, allowing the company to accommodate a subscription from its controlling shareholder who is based overseas and requires additional time to complete necessary processes.
  • The first tranche of the offering, consisting of 7 million units at 50 cents per unit, was fully closed on February 10, 2026.

Key Details

  • Offering Structure:
    • First Tranche (Closed): 7,000,000 units at $0.50 per unit.
    • Second Tranche (Extended): Up to 4,038,462 units at $0.52 per unit.
    • Total Potential Gross Proceeds: Up to $5.6 million ($3.5 million from the first tranche + $2.1 million from the second tranche).
  • Extension Terms: The subscription period for the second tranche is extended by 30 days, with a new closing deadline of April 13, 2026.
  • Purpose of Extension: To allow the company's controlling shareholder, who is based overseas, sufficient time to follow specific processes to participate in the offering.
  • Unit Composition: Each unit consists of one common share and one-half of a warrant.
  • Warrant Terms: Each whole warrant is exercisable to purchase one common share at an exercise price of $1.00.
  • Warrant Duration: The warrants are exercisable for a period of three years after closing.
  • Regulatory Conditions: Completion is subject to customary closing conditions, including receipt of approvals from the TSX Venture Exchange.
  • Hold Periods: All securities issued are subject to hold periods under applicable securities laws.
  • Finders' Fees: The company may pay finders' fees in compliance with applicable laws and subject to exchange approval.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from Comprehensive Healthcare Systems Inc